Why did OpenAI buy a drug development startup?
OpenAI acquired Orchestra Bio, a startup building AI agents that coordinate drug development. When a manufacturing batch fails, its agents find the affected trials, teams and timelines and lay out the options, while people make the final call.
By Aish RegantiAish Reganti

Read the full story
Originally published by Aish Reganti on Nov 4, 2026.
Comments
Sign in to join the discussion.